Related Experiment Video
Updated: Feb 9, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Hemodynamic impact of percutaneous left atrial appendage closure in patients with paroxysmal atrial fibrillation
Lluis Asmarats1, Mathieu Bernier1, Gilles O'Hara1
1Quebec Heart & Lung Institute, Laval University, 2725 chemin Ste-Foy, Quebec City, Quebec, G1V 4G5, Canada.
Insights
Percutaneous left atrial appendage (LAA) closure effectively prevents thromboembolic events in atrial fibrillation (AF) patients. This study found that LAA closure does not significantly alter left atrial or ventricular function, offering a safe alternative to anticoagulation.
Area of Science:
- Cardiology
- Medical Devices
- Cardiac Electrophysiology
Background:
- Percutaneous left atrial appendage (LAA) closure is an established alternative to anticoagulation for preventing thromboembolic events in atrial fibrillation (AF) patients.
- Limited data exist regarding the impact of LAA closure on cardiac function.
Purpose of the Study:
- To evaluate the acute hemodynamic effects of percutaneous LAA closure on left atrial and ventricular function in patients with paroxysmal AF.
Main Methods:
- The study included 31 patients with paroxysmal AF undergoing successful percutaneous LAA closure.
- Transthoracic echocardiography was performed at baseline and post-procedure.
- Cardiac computed tomography (CT) with 3D reconstruction was used in a subset of patients to assess LAA volume.
Main Results:
- Left ventricular systolic function and left atrial volumetric indexes remained unchanged post-LAA closure.
- No significant alterations in left ventricular or left atrial stroke volume were observed.
- The LAA constituted approximately 10% of the total left atrial volume, with no correlation found between LAA/LA ratio and changes in stroke volume.
Conclusions:
- Percutaneous LAA closure does not induce significant acute changes in left atrial or left ventricular function.
- The procedure is hemodynamically neutral concerning cardiac function in patients with paroxysmal AF.
Purpose:
Percutaneous left atrial appendage (LAA) closure has become a valid alternative to anticoagulation therapy for the prevention of thromboembolic events in patients with atrial fibrillation (AF). However, scarce data exist on the impact of LAA closure on left atrial and ventricular function. We sought to assess the acute hemodynamic changes associated with percutaneous LAA closure in patients with paroxysmal AF.
Methods:
The study population consisted of 31 patients (mean age 73 ± 10 years; 49% women) with paroxysmal AF who underwent successful percutaneous LAA closure. All patients were in sinus rhythm and underwent 2D transthoracic echocardiography at baseline and the day after the procedure. A subset of 14 patients underwent preprocedural cardiac computed tomography (CT) with 3D LA and LAA reconstruction.
Results:
Left ventricular systolic function parameters and LA volumetric indexes remained unchanged after the procedure. No significant changes in left ventricular stroke volume (72.4 ± 16.0 vs. 73.3 ± 15.7 mL, p = 0.55) or LA stroke volume (total 15.6 ± 4.2 vs. 14.6 ± 4.2 mL, p = 0.21; passive 9.0 ± 2.8 vs. 8.3 ± 2.6 mL, p = 0.31; active 10.3 ± 5.6 vs. 10.0 ± 6.4 mL, p = 0.72) occurred following LAA closure. Mean ratio of LAA to LA volume by 3D CT was 10.2 ± 2.3%. No correlation was found between LAA/LA ratio and changes in LA stroke volume (r = 0.35, p = 0.22) or left ventricular stroke volume (r = 0.28, p = 0.33).
Conclusions:
The LAA accounts for about 10% of the total LA volume, but percutaneous LAA closure did not translate into any significant changes in LA and left ventricular function.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Surface Appendages of Archaea
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Impact of Groups on Groups

